Page last updated: 2024-10-19

inositol and Body Weight, Fetal

inositol has been researched along with Body Weight, Fetal in 2 studies

Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.

Research Excerpts

ExcerptRelevanceReference
"Valproic acid (VPA) is an anticonvulsant drug that is widely used therapeutically for a variety of neurological conditions."1.33Myo-inositol enhances teratogenicity of valproic acid in the mouse. ( Finnell, RH; Giavini, E; Massa, V; Wlodarczyk, B, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Palladino, E1
Van Mieghem, T1
Connor, KL1
Massa, V1
Wlodarczyk, B1
Giavini, E1
Finnell, RH1

Other Studies

2 other studies available for inositol and Body Weight, Fetal

ArticleYear
Diet Alters Micronutrient Pathways in the Gut and Placenta that Regulate Fetal Growth and Development in Pregnant Mice.
    Reproductive sciences (Thousand Oaks, Calif.), 2021, Volume: 28, Issue:2

    Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Caloric Restriction; Diet; Diet, H

2021
Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Birth defects research. Part A, Clinical and molecular teratology, 2006, Volume: 76, Issue:3

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anticonvulsants; Drug Synergism; Embryo

2006